For Immediate Release
Chicago, IL – October 5, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Adobe (ADBE - Free Report) , United Technologies (UTX - Free Report) , Lockheed Martin (LMT - Free Report) , CVS Health (CVS - Free Report) and Coca-Cola (KO - Free Report) .
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Adobe, United Technologies and Lockheed Martin
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Adobe, United Technologies and Lockheed Martin. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Buy-rankedAdobe’s shares have gained +80% over the past one year, outperforming the Zacks Software industry which has increased +37.7% over the same period. The Zacks analyst thinks Adobe’s creative products are continuing to drive its top-line growth.
The company is currently benefiting from strong demand for its innovative solutions and growing subscriptions for its cloud application. Adobe has been making great efforts toward establishing its presence in cloud-related software areas such as documents and marketing. Adobe Experience Manager, which enables brands to offer a personalized experience, is also witnessing robust growth.
Adobe’s market position, compelling product lines, continued innovation, solid adoption of Creative Cloud and Adobe marketing cloud are major positives. However, lower end-market demand and exposure to Europe remain overhangs.
(You can read the full research report on Adobe here >>>).
Shares of Buy-rankedUnited Technologies have gained +12.8% over the past three months, outperforming the Zacks Diversified Operations industry, which has increased +7.3% over the same period. The company continues to invest in innovative products through higher engineering spend, delivering value to its customers and securing orders that will drive top line growth in future.
The Zacks analyst thinks stronger Otis, Climate Control and Security, Pratt & Whitney and Aerospace Systems sales will continue to drive the company's revenues. Also, the buyout of S2 Security (completed recently) will help in solidifying the company's UTC Climate, Controls & Security segment.
Moreover, the company has received approval from the U.S. Department of Justice from the acquisition of Rockwell Collins. Higher revenues and cost-cutting measures will help in boosting the company's profitability in the quarters ahead. In the past 60 days, earnings estimates on the stock remained stable for 2018 while increased for 2019.
(You can read the full research report on United Technologies here >>>).
Buy-rankedLockheed Martin’s shares have gained +10.4% over the past one year, underperforming the Zacks Aerospace Defense sector, which has gained +24% over the same period. The Zacks analyst emphasizes that Lockheed Martin, being the largest defense contractor in the world, enjoys a strong demand for its high-end military equipment in domestic as well as international markets.
Consequently, strong order growth has been a primary growth driver for this company. Lately, the company has been witnessing strong demand for its equipment, ranging from C-130J aircraft in France and Germany to helicopters in Poland to missile defense systems in the Asia-Pacific, Europe, and Middle East regions.
The company continues to be a strong cash generator, helping it to take important cash deployment decisions. However, the company faces intense competition for its broad portfolio of products and services in both domestic and international markets.
(You can read the full research report on Lockheed Martin here >>>).
Other noteworthy reports we are featuring today include CVS Health and Coca-Cola.
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Click to see them right now >>
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.